Codes / ICD10CM / B43.9

B43.9 Chromomycosis, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Chromomycosis, unspecified
  • ICD-10-CM Code B43.9

Summary

Chromomycosis, unspecified, is a chronic fungal infection affecting the skin and subcutaneous tissues. It is caused by dematiaceous fungi and typically presents as slow-growing, localized lesions. The condition progresses gradually over time and may persist if untreated, leading to tissue damage or secondary complications.

Causes

The infection is caused by dematiaceous (pigmented) fungi, which are found in soil, decaying vegetation, or organic matter. These fungi enter the body through minor skin trauma, such as cuts or puncture wounds, and establish chronic infections in the skin and subcutaneous tissues.

Risk Factors

  • Occupational or recreational exposure to soil, wood, or decaying organic material.
  • Immunocompromised status, including conditions like HIV/AIDS or immunosuppressive therapy.
  • Living in or traveling to tropical or subtropical regions where these fungi are endemic.
  • Minor skin injuries or breaks that allow fungal entry.

Symptoms

  • Slow-growing, painless or mildly tender nodules, plaques, or abscesses on the skin.
  • Lesions may become verrucous (wart-like) or ulcerated over time.
  • Dark pigmentation or discoloration of affected skin areas.
  • Possible lymphatic involvement or satellite lesions.

Diagnosis

Diagnosis involves a combination of clinical evaluation, microscopic examination of tissue samples, and fungal culture. Biopsy of affected tissue may reveal pigmented fungal elements, and culture confirms the presence of dematiaceous fungi. Imaging studies may be used to assess the extent of tissue involvement.

Treatment Options

Treatment typically includes antifungal medications, such as itraconazole or terbinafine, administered over several months. Surgical debridement or excision of lesions may be necessary for severe or refractory cases. Long-term therapy is often required to prevent recurrence.

Prognosis and Follow-Up

With appropriate treatment, the prognosis is generally good, though recovery may be slow. Regular follow-up is important to monitor for recurrence or complications. Immunocompromised patients may require extended or ongoing therapy to manage the infection.

Complications

  • Chronic tissue damage or scarring.
  • Secondary bacterial infections.
  • Lymphatic spread or dissemination in severe cases.
  • Functional impairment due to extensive skin or tissue involvement.

Lifestyle & Prevention

  • Avoid contact with soil or decaying organic matter, especially in endemic regions.
  • Wear protective clothing (e.g., gloves, boots) when handling potentially contaminated materials.
  • Clean and treat minor skin injuries promptly to reduce infection risk.
  • Maintain good overall health to support immune function.

When to Seek Professional Help

Seek medical attention if you develop persistent skin lesions, especially after exposure to soil or organic matter, or if lesions worsen, become painful, or show signs of infection (e.g., redness, swelling, discharge).

Tips for Medical Coders

Use code B43.9 for chromomycosis when the site or specific type is not documented. Ensure documentation supports the diagnosis and specifies whether the infection is localized or disseminated, as this may impact coding accuracy. Verify that the condition is not better classified under a more specific subcategory (e.g., cutaneous or systemic) if detailed information is available.

Book a walkthrough

B43.9 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.